Korea Biomedical Review | 2024-06-27 Mediwhale, a medical AI diagnostic solution provider, said Thursday that it has been selected as a “JLABS” company, benefitting from a global accelerator platform operated by Johnson & Johnson Innovation, a multinational...
ERA 2024, 22 May 2024 Abstract Background We had previously developed a deep-learning-based risk evaluation system from retinalphotographs, Reti-CKD, for stratifying chronic kidney (CKD) development risk in kidney functionpreserved people. This study aims to evaluate...
Privacy policy Mediwhale Inc. (“Mediwhale,” “we, “us,” or “our”) establishes and presents the following privacy policy describing how and why we might collect, store, use, share and/or protect your personal information who use Mediwhale’s website and resolve any...
This website (“Web Site”) is offered to you by Mediwhale, Inc. (“Mediwhale”). The following Terms of Use govern your access and use of this Web Site and its service. Also, specific terms and conditions may apply to specific content, data, materials, or information...
American Heart Association consortium advances development of evidence-based health tech solutions [Seoul, Korea, Sep 30, 2022] – Mediwhale, a retina-based AI company, has joined the American Heart Association Center for Health Technology & Innovation’s...